Mount Sinai Department of Psychiatry

Blood “SECmeres” and extracellular vesicles show promise for Alzheimer RNA biomarkers.

A new blood test approach analyzes RNA inside extracellular vesicles, aiming to spot Alzheimer disease earlier.

Emerging blood RNA tests may analyze brain-derived exosomes to detect Alzheimer disease earlier.

Psychiatrist Craig Katz, MD, shows how resilience-based trauma care reduces stigma, avoids PTSD overdiagnosis, and guides patients.

New patients with cognitive complaints could need trauma screening; CBT shows promise after acute stress.

How disaster psychiatry shifts from forced debriefs to proactive outreach, from Ground Zero to COVID wards—building trauma-ready community care.

Experts weigh benzodiazepine benefits, dependence myths, and safer prescribing in older adults, including what evidence really says about Alzheimer risk.

Experts unpack benzodiazepines in seniors: Beers Criteria, fall risk, Alzheimer bias, and practical low-dose, mindful prescribing strategies.

Clinicians weigh benzodiazepine benefits against dependence fears, with expert guidance on safe prescribing, withdrawal tapering, and long-term anxiety treatment choices.

Learn how community-based supports, clinician self-reflection, and culturally responsive systems close mental health gaps beyond the clinic.

Why care improves when clinicians ask about housing, work, money and access—using culturally responsive tools to uncover hidden stressors.

Learn how psychiatrists ask about identity with curiosity, transparency, and cultural humility—building trust, reducing assumptions, and shaping culturally informed treatment plans.

Explore why sexual health matters after 65 and how clinician comfort boosts disclosure.

Learn more about medication use in pregnancy and postpartum, including risks and benefit analysis.

Analysis of speech, acoustics, and facial cues reveals early psychosis and suicide risk.

Guidance on psychotropic meds in pregnancy: personalize decisions, coordinate care, and plan early to prevent postpartum relapse.

Planning for prevention of perinatal psychiatric relapse with safer medication options.

Computational phenotyping reveals prodromal psychosis clues, connects biomarkers to symptoms, and shows why stress and cannabis reduction matters.

A multicenter study tests SAINT TMS for postpartum depression.

A relationship between inflammatory skin disease and depression revealed in new research.

New research trains cognitive control to curb stimulant cravings.

Eric Nestler, MD, PhD, reflects on his research and new role as dean of the Icahn School of Medicine.

What is the role of GLP-1 agonists in psychiatry? Joseph F. Goldberg, MD, and Roger S. McIntyre, MD, FRCPC, share their thoughts.

Tom Hildebrandt, PsyD, explores how sex hormones influence eating disorders, revealing critical insights into binge eating and bulimia nervosa.

Discover how hormonal differences influence the development of bulimia nervosa and binge eating disorder, revealing potential biomarkers and treatment strategies.

New research reveals how ezogabine targets potassium channels in the brain, offering innovative treatment options for major depressive disorder symptoms.

Fathers share their heartbreaking stories of loss and advocate for a new model of suicide prevention that emphasizes early intervention and awareness at the 2025 APA Annual Meeting.

How does adult ADHD differ from pediatric ADHD? Jeffrey Newcorn, MD, shared his expertise at the 2025 APA Annual Meeting.

Angelo Chaia, MD, explores the impact of long-acting injectables on patients with severe mental illness and substance use disorders at the 2025 APA Annual Meeting.

Rejoyn, a new app being prescribed as a depression treatment, is an emotional face memory task designed to correct abnormal neural circuits.